Identification of People Infected With Hepatitis C Virus Who Have Never Been Diagnosed

G&H What is the current prevalence of hepatitis C virus infection in the United States? KK A recent population-based survey of the United States found […]

Update on the Treatment of Hepatitis C Virus Infection in Patients With Cirrhosis

G&H What is the prevalence of cirrhosis in patients with hepatitis C virus infection, and has it changed over time? PP It is generally accepted […]

Update on the Management of Hepatitis C Virus Infection in the Setting of Chronic Kidney Disease and Kidney Transplantation

Abstract: Hepatitis C virus (HCV) infection is one of the major global health burdens. Chronic HCV infection can increase the risks of proteinuria and chronic […]

Hepatitis C Virus Detection and Treatment in Rural Communities

G&H What explains the increase in hepatitis C virus infection in rural communities? SG Over the past decade, an epidemic of hepatitis C virus (HCV) […]

Care of Patients Following Cure of Hepatitis C Virus Infection

Abstract: The vast majority of persons with chronic hepatitis C virus (HCV) infection will achieve virologic cure with the current direct-acting antiviral therapies. Prevention of […]

Hepatitis C Virus–Viremic Liver Transplantation

G&H For a patient with active hepatitis C virus infection, how do outcomes compare when receiving a liver also infected with active hepatitis C virus […]

Economic Comparison of Serologic and Molecular Screening Strategies for Hepatitis C Virus

Abstract: Background: Hepatitis C virus (HCV) screening is traditionally performed using an enzyme-linked immunosorbent assay (ELISA), and HCV infection is confirmed by measuring the viral […]

Hepatitis C Virus Treatment in Patients With Chronic Kidney Disease and in Kidney Transplant Recipients

Abstract: An important interplay exists between hepatitis C virus (HCV) infection and chronic kidney disease (CKD). HCV infection is associated with an increased risk of […]

Management of Patients Who Have Achieved Sustained Virologic Response for Hepatitis C Virus Infection

G&H How often is sustained virologic response achieved with the current hepatitis C virus treatment options? PP There are multiple direct-acting antiviral (DAA) regimens currently […]

Elimination of Hepatitis B and C Virus Infections

G&H Is it feasible to eliminate hepatitis B and C virus infections in the United States? AA Hepatitis B virus (HBV) and hepatitis C virus (HCV) […]

Shortening Treatment for Hepatitis C Virus Infection

G&H How has treatment duration changed from the first direct-acting antiviral agents to those currently being used in patients with hepatitis C virus infection? SK […]

Gastro-Hep News

US Food and Drug Administration Approves Infliximab Biosimilar On December 14, 2017, the US Food and Drug Administration (FDA) approved the infliximab (Remicade, Janssen) biosimilar infliximab-qbtx […]

Noninvasive Assessment of Fibrosis Regression in Hepatitis C Virus Sustained Virologic Responders

Abstract: The emergence of direct-acting antiviral (DAA) therapies and noninvasive measures of liver fibrosis has streamlined the management of patients with chronic hepatitis C virus […]

Black Box Warning for Possible HBV Reactivation During DAA Therapy for Chronic HCV Infection

Abstract: In 2016, the US Food and Drug Administration issued a warning about the risk of hepatitis B virus (HBV) reactivation in some patients receiving […]

Extrahepatic Benefits Achieved With Sustained Virologic Response in Patients With Hepatitis C Virus Infection

G&H What are the hepatic benefits achieved with sustained virologic response in patients infected with hepatitis C virus? MK In patients with chronic hepatitis C […]

Gastro-Hep News

US Food and Drug Administration Approves 8-Week Treatment for Pangenotypic Hepatitis C Virus Infection On August 3, 2017, the US Food and Drug Administration (FDA) approved […]

Gastro-Hep News

US Food and Drug Administration Approves Treatment for Chronic Hepatitis C Virus Genotypes 1 Through 6 On July 18, 2017, the US Food and Drug Administration […]

Occurrence and Recurrence of Hepatocellular Carcinoma After Successful Direct-Acting Antiviral Therapy for Patients With Chronic Hepatitis C Virus Infection

Abstract: Chronic hepatitis C virus (HCV) infection has generally been associated with a slightly increased risk of developing hepatocellular carcinoma (HCC). For the past several […]

HBV/HCV Coinfection and Possible Reactivation of HBV Following DAA Use

G&H How does coinfection affect hepatitis B and C virus? Are the diseases more severe or resistant? RG When a person has active hepatitis B […]

Hepatitis C Virus Infection in Children

G&H What is the prevalence of hepatitis C virus infection in children? KM In comparison to adults, the prevalence of this disease is relatively low […]